pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 28·1 min read
save

ICON audit finds overstated revenue; Secretome and Psilera raise cash

👀 ICON’s audit probe is complete: The investigation found that ICON’s revenue was overstated by $65.3 million in 2023 (about 0.8% of its total revenue that year) and by $92.7 million in 2024 (1.1% of ...

May 28, 2026·read at Endpoints ↗

May 28, 2026 10:51 AM EDT News Briefing ICON au­dit finds over­stat­ed rev­enue; Se­cre­tome and Psilera raise cash ENDPOINTS 👀 ICON’s au­dit probe is com­plete: The in­ves­ti­ga­tion found that ICON’s rev­enue was over­stat­ed by $65.3 mil­lion in 2023 (about 0.8% of its to­tal rev­enue … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
79 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 11h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 14h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 14h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 15h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 16h agoHealth tech investors are looking at bigger betsEndpoints